Mike Exter
About Mike Exter
Mike Exter serves as the Associate Director of Business Development and Corporate Strategy at ROME Therapeutics, where he has worked since 2023. He has a strong background in business development and consulting, with previous roles at Forma Therapeutics, IQVIA, and IMS Consulting Group, and holds an MBA from Columbia Business School.
Current Role at ROME Therapeutics
Mike Exter serves as the Associate Director of Business Development and Corporate Strategy at ROME Therapeutics. He has been in this role since 2023, contributing to the company's strategic initiatives and business growth. His position involves overseeing business development efforts and aligning corporate strategies to enhance the organization's market presence.
Previous Experience at Forma Therapeutics
Prior to his current role, Mike Exter worked as a Business Development Intern at Forma Therapeutics from 2021 to 2022. During his seven-month tenure, he gained experience in business development processes within the pharmaceutical sector, contributing to various projects that supported the company's strategic objectives.
Professional Background at IQVIA
Mike Exter held multiple positions at IQVIA, starting as an Analyst from 2014 to 2015. He progressed to Consultant from 2017 to 2019, and then served as Manager from 2019 to 2020. Finally, he became Associate Principal from 2020 to 2021. His roles involved consulting on healthcare strategies and business development, enhancing his expertise in the industry.
Education and Expertise
Mike Exter earned his Master of Business Administration (MBA) from Columbia Business School, where he studied from 2021 to 2023. He also holds a Bachelor of Arts in Financial Economics from Columbia University, which he completed from 2010 to 2014. His educational background provides a strong foundation for his roles in business development and corporate strategy.
Internship Experience
In addition to his roles at Forma Therapeutics, Mike Exter has completed several internships. He interned at C4 Therapeutics, Inc. in 2023 for ten months and at Curie.bio in 2022 for two months. These internships allowed him to further develop his skills in business development within the biotechnology sector.